Skip to main content
. 2020 Sep 1;9(9):565. doi: 10.3390/antibiotics9090565

Table 4.

Subgroup analysis for comparison of prevalence of VRE among isolate sources.

Isolate Source Number of Studies Prevalence (%) 95% CI I2 (%) Q Heterogeneity Test
DF p
Clinical 8 19.9 12.5–27.2 195.18 145.362 7 <0.001
Environmental 7 27.2 17.3–37.2 95.33 128.519 6 <0.001
Animal 4 32.9 5.1–60.7 96.37 82.535 3 <0.001
Overall 19 25.3 19.8–30.8 96.26 480.667 18 <0.001